Product Description

Fluvac Innovator® vaccines deliver demonstrated protection against circulating contemporary equine influenza viruses (EIV). Fluvac Innovator vaccines aid in the prevention of equine influenza due to type A2 viruses; encephalomyelitis due to Eastern, and Western viruses; and tetanus.

Features & Benefits

• Vaccination before exposure is the best way to combat EIV
• At-risk horses (those less than 6 years of age, senior horses and horses that may be frequently exposed to EIV at outside events) should be vaccinated for EIV every six months
• Fluvac Innovator is the only vaccine with EIV strain KY/97 that has demonstrated protection against heterologous challenge with EIV strain OH/03
• In a study, Fluvac Innovator has been shown to be cross-reactive against three newly emerging equine influenza viruses, including Ayrshire 2013 (AY/13) a European Clade 2 isolate, Kentucky 2014 (KY/14), and Texas 2012 (TX/12) recent North American Clade 1 isolates
• Fluvac Innovator is the only EIV vaccine shown to help protect against clinical signs for seven months against a heterologous, dual-strain challenge
• In addition to helping protect against EIV, Fluvac Innovator vaccines also contain both EHV-1 and EHV-4 to help protect against rhinopneumonitis
• Only Innovator vaccines are adjuvanted with MetaStim® to help amplify the horse’s immune response